Getinge receives FDA premarket approval for the iCast covered stent system

514

Getinge‘s iCast covered stent system has received premarket approval from the Food and Drug Administration (FDA) for the treatment of patients with iliac arterial occlusive disease.

The iCast covered stent system, sold outside the U.S. under the brand name Advanta V12, has been used by clinicians for 20 years and is the most clinically evaluated balloon expandable polytetrafluoroethylene (ePTFE)-covered stent in the world, with clinical data published in more than 550 articles.

LEAVE A REPLY

Please enter your comment!
Please enter your name here